Gulfport, Mississippi • Velocity Clinical Research
Phone: (228) 206-1283
If someone you live with has tested positive for COVID-19, you may be eligible for a study of an investigational medication intended to help prevent COVID-19 infection.
Velocity is conducting a study for an investigational drug intended to prevent COVID-19. In this placebo-controlled study, participants may receive a non-active placebo to see how it compares to the investigational drug.
For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.
©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy